{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Pathophysiology and Treatment of Malignant Hyperthermia
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Learning Objectives
After completing this continuing education activity you will be able to:
- Identify a triggering agent for MH.
- Explain treatment considerations for a patient with MH.
- Recognize potential complications of MH and dantrolene administration.
Disclosures
The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.
Price:
$21.95
Credits:
- ANCC 2.0 CH / 2.0 APH
- DC - BON 2.0 CH
- FL - BON 2.0 CH
- GA - BON 2.0 CH
Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.
Awarded Advanced Pharmacology Hours
Awarded Advanced Pharmacology Hours
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: AENJ0421A
Published: Apr/Jun 2021
Expires: 6/6/2025
Collections:
Acute Care Adult/Gerontology Nurse Practitioner Subscription
,
CESaver
,
Critical Care Nursing (Adult) Subscription
Sources:
Advanced Emergency Nursing Journal
Required Passing Score: 8/10 (80%)
Categories:
Acute Care
,
Advanced Pharmacology Hours
,
Advanced Practice Nursing
,
Anesthesia
,
Cardiovascular
,
Drug Therapy
,
Emergency Care
,
Medical-Surgical
,
Surgery